Search the Newsreel

NKLR: Micromodular reactor SOLO secures $4B in commitments, targeting rapid, global deployment

NKLR SOLO, a micromodular nuclear reactor, has secured over $4 billion in pre-commercial commitments and is moving toward commercialization. Its design is non-proliferant and scalable, allowing for quick deployment in various markets such as data centers and global infrastructure. This development is based on …

Terra Innovatum at Canaccord growth conference: push for fast nuclear scale

Terra Innovatum presented its SOLO micromodular reactor at Canaccord Genuity's 46th Annual Growth Conference, emphasizing its aim for rapid nuclear scale through safety-by-design principles, low-enriched uranium, and factory-based manufacturing. The company is actively working to convert over 200 units in memoranda of understanding, representing …

COOKE & BIELER LP Trims Winnebago Industries Inc (WGO) Stake -- Shares Remain 31% Undervalued on GF Value

COOKE & BIELER LP has reduced its stake in Winnebago Industries Inc (WGO) by 26.83%, selling 468,112 shares, but still maintains a 4.50% ownership. Despite the sale, which occurred at $31.24 per share, the stock has since risen to $32.79 and is considered significantly …

ONTO January 2028 Options Begin Trading

Investors in Onto Innovation Inc (Symbol: ONTO) saw new options begin trading today, for the January 2028 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 527 days …

Hindware Home Innovation: கடன் குறைந்தது, குழாய் விற்பனை அதிகரித்தது! லாபத்தில் மந்தநிலை?

China Innovation Investment Reports Unaudited NAV Per Share of HK$0.044

Innventure Inc (INV) Q2 2026 Earnings Report Preview: What To Look For

Innventure Inc (INV) is preparing to release its Q2 2026 earnings report on August 13, 2026, with revenue expected to be $1.97 million and earnings at -$0.38 per share. For the full year 2026, revenue estimates have been adjusted down to $32.67 million, while …

BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price

Columbus McKinnon Corporation (NASDAQ:CMCO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Columbus McKinnon Corporation (NASDAQ:CMCO) has received a consensus "Moderate Buy" rating from brokerages, with an average 12-month price target of $23.00, suggesting potential upside from its current share price of $19.55. The company recently reported strong quarterly earnings, beating estimates with $0.61 EPS and …

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Given Consensus Rating of "Buy" by Brokerages

Innovative Solutions and Support, Inc. (ISSC) has received a consensus "Buy" rating from five brokerages, with an average 12-month price target of $16.25, despite recent downgrades to "Hold" by Weiss Ratings, Zacks Research, and Wall Street Zen. The company recently reported better-than-expected quarterly EPS …

HC Wainwright Issues Positive Forecast for Innoviva Earnings

FY2026 EPS Estimates for Innate Pharma Reduced by Analyst

Innodata (INOD) Is Down 10.7% After New CEO, ATM Offering And AI Cyber Suite Launch - What's Changed

Innodata (INOD) recently reported strong Q2 2026 results with increased sales and earnings, reaffirmed its full-year 2026 revenue growth guidance of at least 40%, and announced a new CEO, Rahul Singhal. The company also filed a US$300 million at-the-market equity offering and launched an …

Why Regulation Still Sets The Pace For British American Tobacco (LSE:BATS) And Seed Innovations (LSE:SEED)

Can Chill Brands Group (LSE:CHLL) And Seed Innovations (LSE:SEED) Rebuild Confidence Through Governance?

Barclays Sticks to Its Hold Rating for Innovex International (INVX)

InnovAge Holding Corp (INNV) Earnings Forecast: Future EPS & Revenue Growth Estimates

Dimensional Fund Advisors LP Sells 200,688 Shares of Summit Hotel Properties, Inc. $INN

Dimensional Fund Advisors LP reduced its stake in Summit Hotel Properties (NYSE:INN) by 13.3% in the first quarter, selling 200,688 shares but still holding 1.31 million shares valued at $5.77 million. The REIT reported stronger-than-expected Q1 earnings of $0.04 EPS and revenue of $199.02 …

MCX, Thyrocare, Innova Captab: Top stocks to trade — key levels, target prices & stop loss

Pinnacle Investment Management Group (ASX:PNI) Shares Slip as Investors Track Financial Sector Sentiment

Innovative Industrial Properties (IIPR) Following Earnings Strength Still Looks Undervalued To Some

INIT INNOVATION IN TRAFFIC SYSTEMS AKTIE: AI-Analysen, Prognose & Kursziel

Reflecting On Regional Banks Stocks’ Q2 Earnings: Pinnacle Financial Partners (NASDAQ:PNFP)

Innate Pharma (NASDAQ:IPHA) Stock Rating Upgraded by Leerink Partners

Leerink Partners has upgraded Innate Pharma (NASDAQ:IPHA) from "market perform" to "outperform" with a $4.00 price target, suggesting an 80% upside. This follows similar upgrades from Citigroup and a higher price target from HC Wainwright, contributing to a consensus "Moderate Buy" rating and an …

Winnebago Industries, Inc. (NYSE:WGO) Given Consensus Rating of "Hold" by Brokerages

Winnebago Industries (NYSE:WGO) has received a consensus "Hold" rating from 12 brokerages, with an average 12-month price target of $36.33. The company missed its quarterly earnings and revenue estimates, reporting $0.66 EPS and $698.7 million in revenue, leading to a 9.9% year-over-year revenue decline. …

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

SS Innovations International, Inc. (Nasdaq: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as its new Chief Financial Officer, effective August 3, 2026. Romano brings over two decades of experience in financial leadership, capital strategy, and corporate growth within the …

UBS Group AG Reduces Stake in Summit Hotel Properties Inc (INN) by 32%

UBS Group AG has reduced its stake in Summit Hotel Properties Inc (INN) by 31.97%, selling over 4.1 million shares. Despite this significant reduction, INN represents only 0.01% of UBS's total portfolio. Summit Hotel Properties is a REIT focusing on upscale select-service hotels, currently …

Pinnacle West VP Blankenship sells $97,181 in common stock

Elizabeth A. Blankenship, VP, Controller and CAO at Pinnacle West Capital Corp (NASDAQ:PNW), sold 980 shares of common stock for $97,181 on August 10, 2026, at a price of $99.165 per share. After the sale, Ms. Blankenship directly holds 10,886 shares and indirectly holds …

Pinnacle West SVP Jose Luis Esparza Jr sells $183,618 in stock

Jose Luis Esparza Jr., SVP Public Policy at APS (a subsidiary of Pinnacle West Capital Corp), sold 1,800 shares of the company's common stock for $183,618. Following this transaction, Esparza directly holds 4,910 shares. Pinnacle West Capital Corp. appears overvalued but offers an attractive …

Elizabeth Blankenship Sells 980 Shares of Pinnacle West Capital (NYSE:PNW) Stock

Elizabeth Blankenship, Chief Accounting Officer of Pinnacle West Capital (NYSE:PNW), sold 980 shares of the company's stock for approximately $97,187, reducing her ownership by 8.26%. This insider sale comes as the company reported quarterly EPS slightly below estimates but saw revenue increase by 7.1% …

Insider Selling: Pinnacle West Capital (NYSE:PNW) SVP Sells $183,618.00 in Stock

Pinnacle West Capital (NYSE:PNW) SVP Jose Luis Esparza Jr. sold 1,800 shares of the company's stock for $183,618.00 on August 7th, reducing his holdings by 26.83%. The sale follows the company's recent earnings report, where it missed EPS consensus but saw a 7.1% rise …

InnovAge Holding Corp (INNV) Shares Fall 6.4% -- What GF Score of 62 Tells Investors

InnovAge Holding Corp (INNV) shares dropped 6.4% to $10.23, indicating it is 55.9% overvalued according to GuruFocus's GF Value estimate. Despite a strong financial strength sub-rank of 7/10, its overall GF Score of 62/100 is dragged down by weak valuation (3/10) and momentum (3/10) …

FBIN: Strategic realignment targets faster innovation, cost savings, and improved service by year-end

FBIN Management has announced a strategic refocus to prioritize external customer needs, decentralize marketing, and accelerate product innovation. The company aims for $70 million in cost savings by year-end, expects service levels to normalize, and plans to allocate capital towards organic growth and shareholder …

Three Innoviva therapies named finalists for Prix Galien award

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., announced that three of its infectious disease therapies—XACDURO, ZEVTERA, and NUZOLVENCE—have been named finalists for the 2026 Prix Galien USA Award in the Best Pharmaceutical Product category. This marks the third consecutive year an Innoviva product …

Fortune Brands Innovations (FBIN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Vice President, Finance, and Investor Relations - Curt WorthingtonChief Executive Officer - Jesse SinghChief Operating Officer - David BarryInterim Chief Financial Officer - Ashley George TAKEAWAYS Net Sales …

Onto Innovation Jumps 7.5% After Needham Maintains Buy

Onto Innovation Inc. shares surged 7.5% to $313.29 after three Wall Street firms, including Needham, Evercore ISI Group, and Jefferies, upgraded their price targets, signaling increased confidence in the semiconductor equipment maker. Needham raised its target from $330 to $360, Evercore ISI Group from …